Amphastar Pharmaceuticals (AMPH) Earnings Date, Estimates & Call Transcripts → Read this before you buy AI stocks (From InvestorPlace) (Ad) Free AMPH Stock Alerts $43.05 -0.43 (-0.99%) (As of 01:57 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (Feb. 28) $0.81 Missed By -$0.03 Consensus EPS (Feb. 28) $0.84 Get Amphastar Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for AMPH and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAMPH Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AMPH Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceBoost your retirement with these AI payoutsBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. Amphastar Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241$0.72$0.72$0.72Q2 20241$0.72$0.72$0.72Q3 20241$1.01$1.01$1.01Q4 20241$1.03$1.03$1.03FY 20244$3.48$3.48$3.48AMPH Earnings Date and InformationAmphastar Pharmaceuticals last posted its quarterly earnings data on February 28th, 2024. The reported $0.81 earnings per share for the quarter, missing the consensus estimate of $0.84 by $0.03. The business earned $178.11 million during the quarter, compared to analysts' expectations of $174.90 million. Amphastar Pharmaceuticals has generated $2.89 earnings per share over the last year ($2.89 diluted earnings per share) and currently has a price-to-earnings ratio of 14.9. Earnings for Amphastar Pharmaceuticals are expected to grow by 18.18% in the coming year, from $3.41 to $4.03 per share. Amphastar Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Amphastar Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024Estimated)------- 2/28/2024Q4 2023$0.84$0.81($0.03)$0.94$174.90 million$178.11 million11/8/2023Q3 2023$0.67$1.08+$0.41$1.25$170.65 million$180.56 million8/8/2023Q2 2023$0.52$0.58+$0.06$0.67$137.20 million$145.71 million5/9/2023Q1 2023$0.40$0.52+$0.12$0.54$130.50 million$140.02 million2/28/2023Q4 2022$0.34$0.67+$0.33$0.68$126.43 million$135.02 million11/7/2022Q3 2022$0.32$0.32-$0.34$126.20 million$120.13 million Get the Latest News and Ratings for AMPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amphastar Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q2 2022$0.30$0.33+$0.03$0.33$118.17 million$123.47 million 5/9/2022Q1 2022$0.33$0.47+$0.14$0.47$110.60 million$120.37 million 3/10/2022Q4 2021$0.38$0.42+$0.04$0.45$111.38 million$120.89 million 11/8/2021Q3 2021$0.24$0.46+$0.22$0.33$103.00 million$112.20 million 8/8/2021Q2 2021$0.21$0.21-$0.26$101.38 million$101.66 million Amphastar Pharmaceuticals Earnings - Frequently Asked Questions When is Amphastar Pharmaceuticals's earnings date? Amphastar Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on AMPH's earnings history. Did Amphastar Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Amphastar Pharmaceuticals (NASDAQ:AMPH) missed the analysts' consensus estimate of $0.84 by $0.03 with a reported earnings per share (EPS) of $0.81. Learn more on analysts' earnings estimate vs. AMPH's actual earnings. How much revenue does Amphastar Pharmaceuticals generate each year? Amphastar Pharmaceuticals (NASDAQ:AMPH) has a recorded annual revenue of $644.40 million. How much profit does Amphastar Pharmaceuticals generate each year? Amphastar Pharmaceuticals (NASDAQ:AMPH) has a recorded net income of $137.54 million. AMPH has generated $2.89 earnings per share over the last four quarters. What is Amphastar Pharmaceuticals's price-to-earnings ratio? Amphastar Pharmaceuticals (NASDAQ:AMPH) has a trailing price-to-earnings ratio of 14.90 and a forward price-to-earnings ratio of 12.62. The price/earnings-to-growth ratio is 1.06. What is Amphastar Pharmaceuticals's EPS forecast for next year? Amphastar Pharmaceuticals's earnings are expected to grow from $3.41 per share to $4.03 per share in the next year, which is a 18.18% increase. More Earnings Resources from MarketBeat Related Companies: Catalyst Pharmaceuticals Earnings Results Agios Pharmaceuticals Earnings Results Keros Therapeutics Earnings Results Galapagos Earnings Results Deciphera Pharmaceuticals Earnings Results Amneal Pharmaceuticals Earnings Results Rocket Pharmaceuticals Earnings Results Syndax Pharmaceuticals Earnings Results Zai Lab Earnings Results NewAmsterdam Pharma Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-Turn This page (NASDAQ:AMPH) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock Digest Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.